Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria-Rosa Ghigna

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
The Journal of Liquid Biopsy|March 3, 2025
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experienceClaudia Parisi, José Carlos Benitez, Hélène Lecourt, et al.
The European Respiratory Journal|February 22, 2020
Phenotype and outcome of pulmonary arterial hypertension patients carrying a <i>TBX4</i> mutationPierre Thoré, Barbara Girerd, Xavier Jaïs, et al.
JCI Insight|November 10, 2025
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunctionAnaïs Saint-Martin Willer, Grégoire Ruffenach, Bastien Masson, et al.
The European Respiratory Journal|April 30, 2021
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertensionHélène Le Ribeuz, Lucie To, Maria-Rosa Ghigna, et al.
JTO Clinical and Research Reports|January 13, 2025
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated TumorsAlissa J Cooper, Andrea Arfe, Biagio Ricciuti, et al.
JAMA Oncology|May 29, 2025
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung CancerArianna Marinello, Maria Rosa Ghigna, Julia K Rotow, et al.
American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1Etienne-Marie Jutant, Xavier Jaïs, Barbara Girerd, et al.
American Journal of Respiratory Cell and Molecular Biology|March 27, 2020
Comparison of Human and Experimental Pulmonary Veno-Occlusive DiseaseGrégoire Manaud, Esther J Nossent, Mélanie Lambert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2023
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET FusionMihaela Aldea, Arianna Marinello, Michael Duruisseaux, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Liquid Biopsy|March 3, 2025
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experienceClaudia Parisi, José Carlos Benitez, Hélène Lecourt, et al.
The European Respiratory Journal|February 22, 2020
Phenotype and outcome of pulmonary arterial hypertension patients carrying a <i>TBX4</i> mutationPierre Thoré, Barbara Girerd, Xavier Jaïs, et al.
JCI Insight|November 10, 2025
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunctionAnaïs Saint-Martin Willer, Grégoire Ruffenach, Bastien Masson, et al.
The European Respiratory Journal|April 30, 2021
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertensionHélène Le Ribeuz, Lucie To, Maria-Rosa Ghigna, et al.
JTO Clinical and Research Reports|January 13, 2025
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated TumorsAlissa J Cooper, Andrea Arfe, Biagio Ricciuti, et al.
JAMA Oncology|May 29, 2025
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung CancerArianna Marinello, Maria Rosa Ghigna, Julia K Rotow, et al.
American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1Etienne-Marie Jutant, Xavier Jaïs, Barbara Girerd, et al.
American Journal of Respiratory Cell and Molecular Biology|March 27, 2020
Comparison of Human and Experimental Pulmonary Veno-Occlusive DiseaseGrégoire Manaud, Esther J Nossent, Mélanie Lambert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2023
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET FusionMihaela Aldea, Arianna Marinello, Michael Duruisseaux, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
Pageof 7